CCJ Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Cameco Corp (CCJ) is a strong buy for a beginner investor with a long-term focus and $50,000-$100,000 available for investment. The stock benefits from bullish technical indicators, positive catalysts in the nuclear energy sector, strong financial performance, and favorable analyst ratings.
The technical indicators for CCJ are bullish. The MACD histogram is positive and expanding, the RSI is neutral, and the moving averages (SMA_5 > SMA_20 > SMA_200) indicate an upward trend. The stock is trading near its resistance level (R1: 121.078), suggesting momentum. The pre-market price increase of 2.01% also supports a positive outlook.
The U.S. uranium market faces a significant supply-demand gap, which benefits producers like Cameco.
The U.K. government approved small modular reactors, boosting nuclear energy stocks.
Cameco is projected to account for 15% of global uranium production by 2025, and global electricity demand is expected to rise by 40% by
Accelerating momentum in nuclear new builds globally, with over 75 reactors under construction.
The options data shows a higher open interest in puts, which may indicate some caution among investors.
Analyst price target adjustments include minor downward revisions from Scotiabank and Canaccord, though the overall ratings remain positive.
In Q4 2025, Cameco reported strong financial growth: Revenue increased by 1.50% YoY to $1.2 billion, Net Income surged 46.94% YoY to $199.07 million, EPS rose 48.39% YoY to $0.46, and Gross Margin improved by 7.68% YoY to 22.72%. This demonstrates robust profitability and operational efficiency.
Analysts are bullish on CCJ, with multiple 'Buy' and 'Outperform' ratings. RBC raised its price target to C$160, citing tight uranium market fundamentals and accelerating nuclear construction. Goldman Sachs increased its target to $131, highlighting Cameco's growth potential. While Scotiabank and Canaccord slightly lowered their targets, they maintained positive ratings.
